CLOV vs GMED · rev $1.37B vs P/E 42, rev $2.52B
Clover Health Investments Corp (CLOV) versus Globus Medical (GMED) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Globus Medical (GMED) is a medical devices company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported GMED revenue for 2024-12-31 was $2.52B. Net income was $103.0M. Revenue was up 60.6% from 2023-12-31 to 2024-12-31. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
CLOV currently screens at market cap $1.55B. GMED currently screens at market cap $7.66B and trailing P/E 42.1.
Not investment advice. Open the CLOV and GMED stock pages for the full models.
Not investment advice.